
|Articles|November 15, 2004
IntraLase IPO raises $87M for future growth
Irvine, CA-IntraLase Corp. glided into the public realm in early October with a successful initial public offering (IPO) at the top of its indicated range, selling nearly 7.3 million shares and raising $86.6 million.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
3
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
4
Avisi Technologies releases positive 12-month data from VITA Trial
5


















































.png)


